|
Chemotherapy is the use of anti-cancer drugs that are injected
into a vein or into the cerebrospinal fluid (CSF) or are taken by mouth
to destroy or control cancer cells. Except when given into the CSF,
these drugs enter the bloodstream and reach all areas of the body,
making this treatment useful for cancers such as leukemia that spread
throughout the body.
Doctors give chemotherapy in cycles, with each period of
treatment followed by a rest period to allow the body time to recover.
Chemotherapy cycles generally last about 3 to 4 weeks. Chemotherapy is
often not recommended for patients in poor health, but advanced age by
itself is not a barrier to getting chemotherapy.
Two main groups of chemotherapy drugs are used to treat CLL.
Purine analogs include fludarabine (Fludara), pentostatin
(Nipent), and cladribine (2-CdA, Leustatin). Fludarabine is often one
of the first drugs used against CLL. These drugs can have major side
effects, including an increased risk of infection.
Alkylating agents, which include chlorambucil (Leukeran) and
cyclophosphamide (Cytoxan), have been around much longer. They are
often used along with a purine analog or with other chemotherapy drugs.
They may also be used by themselves (or along with a steroid drug),
especially in people who can't tolerate more aggressive treatment.
A newer drug called bendamustine (Treanda) has properties of
both purine analogs and alkylating agents.
Other drugs sometimes used for CLL include doxorubicin,
vincristine, etoposide, cytarabine (ara-C), and prednisone.
Possible side effects
Chemotherapy drugs work by attacking cells that are dividing
quickly, which is why they work against cancer cells. But other cells
in the body, such as those in the bone marrow, the lining of the mouth
and intestines, and the hair follicles, also divide quickly. These
cells are also likely to be affected by chemotherapy, which can lead to
side effects.
The side effects of chemotherapy depend on the type and dose
of drugs given and the length of time they are taken. These side
effects may include:
- hair loss
- mouth sores
- loss of appetite
- nausea and vomiting
- increased risk of infections (due to low white blood cell
counts)
- easy bruising or bleeding (due to low blood platelets)
- fatigue (due to low red blood cells)
- These side effects are usually short-term and go away once
treatment is finished. There are often ways to lessen these side
effects. For example, there are drugs to help prevent or reduce nausea
and vomiting. Be sure to ask your doctor or nurse about medicines to
help reduce side effects, and let him or her know when you do have side
effects so they can be managed effectively.
Drugs known as growth factors (G-CSF and GM-CSF, for example)
are sometimes given to increase the white blood cell counts and thus
reduce the chance of infection.
If your white blood counts are very low during treatment, you
can reduce your risk of infection by carefully avoiding exposure to
germs. During this time, your doctor may tell you to:
- wash your hands often.
- avoid fresh, uncooked fruits and vegetables and other foods
that might carry germs.
- avoid fresh flowers and plants because they may carry mold.
- make sure other people wash their hands when they come in
contact with you.
- avoid large crowds and people who are sick (wearing a
surgical mask offers some protection in these situations).
Antibiotics may be given before there are signs of infection
or at the earliest sign that an infection may be developing. Drugs that
help prevent viral and fungal infections may also be given.
Because many of the side effects of chemotherapy are caused by
low white blood cell counts, some people find it helpful to keep track
of their counts. If you are interested in this, ask your doctor or
nurse about your blood cell counts or other blood tests and what these
numbers mean.
If platelet counts are low, you may be given drugs or platelet
transfusions to help protect against bleeding. Shortness of breath and
extreme fatigue caused by low red blood cell counts may be treated with
drugs or with red blood cell transfusions.
Last Medical Review: 07/27/2009 Last Revised: 07/27/2009
|